66 related articles for article (PubMed ID: 18519756)
1. Focal adhesion kinase expression in human neuroblastoma: immunohistochemical and real-time PCR analyses.
Beierle EA; Massoll NA; Hartwich J; Kurenova EV; Golubovskaya VM; Cance WG; McGrady P; London WB
Clin Cancer Res; 2008 Jun; 14(11):3299-305. PubMed ID: 18519756
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma.
Stewart JE; Ma X; Megison M; Nabers H; Cance WG; Kurenova EV; Beierle EA
Mol Carcinog; 2015 Jan; 54(1):9-23. PubMed ID: 23868727
[TBL] [Abstract][Full Text] [Related]
3. Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival.
Gillory LA; Stewart JE; Megison ML; Waters AM; Beierle EA
J Surg Res; 2015 Jun; 196(2):339-49. PubMed ID: 25862488
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell lines.
Beierle EA; Ma X; Stewart JE; Megison M; Cance WG; Kurenova EV
Mol Carcinog; 2014 Mar; 53(3):230-42. PubMed ID: 23065847
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of diaminopyrimidine derivatives as novel focal adhesion kinase inhibitors.
Sun Y; Gao Z; Wang R; Zhang G; Wu T; Yin W; Sun Y; Qin Q; Zhao D; Cheng M
RSC Med Chem; 2023 Nov; 14(11):2301-2314. PubMed ID: 37974962
[TBL] [Abstract][Full Text] [Related]
6. Metastasis in neuroblastoma: the
Bhavsar SP
Front Oncol; 2023; 13():1196861. PubMed ID: 37274289
[TBL] [Abstract][Full Text] [Related]
7. Potential Focal Adhesion Kinase Inhibitors in Management of Cancer: Therapeutic Opportunities from Herbal Medicine.
Chen F; Zhong Z; Zhang C; Lu Y; Chan YT; Wang N; Zhao D; Feng Y
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362132
[TBL] [Abstract][Full Text] [Related]
8. The Extracellular Matrix and Neuroblastoma Cell Communication-A Complex Interplay and Its Therapeutic Implications.
Horwacik I
Cells; 2022 Oct; 11(19):. PubMed ID: 36231134
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of potent FAK-degrading PROTACs.
Qin Q; Wang R; Fu Q; Zhang G; Wu T; Liu N; Lv R; Yin W; Sun Y; Sun Y; Zhao D; Cheng M
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2241-2255. PubMed ID: 35978496
[TBL] [Abstract][Full Text] [Related]
10. Serine-Threonine Kinase Receptor Associate Protein (STRAP) confers an aggressive phenotype in neuroblastoma via regulation of Focal Adhesion Kinase (FAK).
Bownes LV; Marayati R; Quinn CH; Hutchins SC; Stewart JE; Anderson JC; Willey CD; Datta PK; Beierle EA
J Pediatr Surg; 2022 Jun; 57(6):1026-1032. PubMed ID: 35272839
[TBL] [Abstract][Full Text] [Related]
11. Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma.
Musumeci F; Cianciusi A; D'Agostino I; Grossi G; Carbone A; Schenone S
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885651
[TBL] [Abstract][Full Text] [Related]
12. CD146 is a potential immunotarget for neuroblastoma.
Obu S; Umeda K; Ueno H; Sonoda M; Tasaka K; Ogata H; Kouzuki K; Nodomi S; Saida S; Kato I; Hiramatsu H; Okamoto T; Ogawa E; Okajima H; Morita K; Kamikubo Y; Kawaguchi K; Watanabe K; Iwafuchi H; Yagyu S; Iehara T; Hosoi H; Nakahata T; Adachi S; Uemoto S; Heike T; Takita J
Cancer Sci; 2021 Nov; 112(11):4617-4626. PubMed ID: 34464480
[TBL] [Abstract][Full Text] [Related]
13. FAK inhibitors as promising anticancer targets: present and future directions.
Mustafa M; Abd El-Hafeez AA; Abdelhafeez DA; Abdelhamid D; Mostafa YA; Ghosh P; Hayallah AM; A Abuo-Rahma GE
Future Med Chem; 2021 Sep; 13(18):1559-1590. PubMed ID: 34340532
[TBL] [Abstract][Full Text] [Related]
14. EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth.
Bownes LV; Williams AP; Marayati R; Stafman LL; Markert H; Quinn CH; Wadhwani N; Aye JM; Stewart JE; Yoon KJ; Mroczek-Musulman E; Beierle EA
PLoS One; 2021; 16(3):e0246244. PubMed ID: 33690617
[TBL] [Abstract][Full Text] [Related]
15. Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its Potential as a Therapeutic Target.
Aboubakar Nana F; Vanderputten M; Ocak S
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31671774
[TBL] [Abstract][Full Text] [Related]
16. The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor.
Aye JM; Stafman LL; Williams AP; Garner EF; Stewart JE; Anderson JC; Mruthyunjayappa S; Waldrop MG; Goolsby CD; Markert HR; Quinn C; Marayati R; Mroczek-Musulman E; Willey CD; Yoon KJ; Whelan KF; Beierle EA
Oncotarget; 2019 Sep; 10(53):5534-5548. PubMed ID: 31565187
[TBL] [Abstract][Full Text] [Related]
17. Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts.
Stafman LL; Williams AP; Marayati R; Aye JM; Markert HR; Garner EF; Quinn CH; Lallani SB; Stewart JE; Yoon KJ; Whelan K; Beierle EA
Sci Rep; 2019 Sep; 9(1):13259. PubMed ID: 31519958
[TBL] [Abstract][Full Text] [Related]
18. Focal adhesion kinase (FAK) phosphorylation is a key regulator of embryonal rhabdomyosarcoma (ERMS) cell viability and migration.
Al-Ghabkari A; Qasrawi DO; Alshehri M; Narendran A
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1461-1469. PubMed ID: 31006845
[TBL] [Abstract][Full Text] [Related]
19. Activation of cell migration via morphological changes in focal adhesions depends on shear stress in MYCN-amplified neuroblastoma cells.
Hiraiwa T; Yamada TG; Miki N; Funahashi A; Hiroi N
J R Soc Interface; 2019 Mar; 16(152):20180934. PubMed ID: 30836897
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
